Mainz Biomed Stock (NASDAQ: MYNZ) stock price, news, charts, stock research, profile.
You can purchase shares of Mainz Biomed (NASDAQ:MYNZ) through any online brokerage.
Other companies in Mainz Biomed’s space includes: CERo Therapeutics Hldgs (NASDAQ:CERO), Vincerx Pharma (NASDAQ:VINC), Immuron (NASDAQ:IMRN), Can Fite Biofarma (AMEX:CANF) and BioRestorative Therapies (NASDAQ:BRTX).
Mainz Biomed has a consensus price target of $11.00.
The stock price for Mainz Biomed (NASDAQ: MYNZ) is $4.71 last updated January 13, 2025 at 4:31 PM EST.
There are no upcoming dividends for Mainz Biomed.
Mainz Biomed’s Q4 earnings are confirmed for Tuesday, April 8, 2025.
There is no upcoming split for Mainz Biomed.
Mainz Biomed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.